logo
  • HOME
  • PRODUCT
  • ABOUT
  • CONTACT
  • MEDPRIN(Germany)
  • MEDPRIN(China)
CE Certified!<br>StypCel™ Absorbable Hemostat
CE Certified!
StypCel™ Absorbable Hemostat
Your health is all that matters.
New trend of cranioplasty
New trend of cranioplasty
Neurosurgical Solution Provider
Neurosurgical Solution Provider
ReDura™, NeoDura™, Recranio™ - Cranial Closure
Welcome To Visit Us
Welcome To Visit Us
- Aarb Health, Dubai, UAE, January 30-Febuary 2, 2023 - AANS, Los Angeles, USA, April 21-24, 2023 - FIME, Miami, USA, June 21-23, 2023 - EANS, Barcelona, Spain, September 24-28, 2023 - MEDICA , Düsseldorf, Germany, November 13-16, 2023 - WFNS, Cape Town, South Africa, December 4-8, 2023

MEDPRIN News

Discover More
Recranio™, the International Webinar between Columbia and Spain
Recranio™, the International Webinar between Columbia and Spain
2021.06.05
November 18-21
November 18-21
2021.06.05
Pre-clinical experiment with swine model
Pre-clinical experiment with swine model
2021.06.05

Products exploration

Show All
ReDura™ Synthetic Dural Sustitute
NeoDura™ Novel Dural Patch
Recranio™ Cranio-Maxillofacial repair system
StypCel™Absorbable Hemostat
Retissue™
Teeth Aligner
LivPrint™
ReDura™ Synthetic Dural Sustitute
ReDura™ Synthetic Dural Sustitute
NeoDura™ Novel Dural Patch
NeoDura™ Novel Dural Patch
Recranio™ Cranio-Maxillofacial repair system
Recranio™ Cranio-Maxillofacial repair system
StypCel™Absorbable Hemostat
StypCel™Absorbable Hemostat
Retissue™
Retissue™
Teeth Aligner
Teeth Aligner
LivPrint™
LivPrint™
up
Contact Us
Medprin Regenerative Medical Technologies Co., Ltd.
No.3 Yayingshi Road, Huangpu District, Guangzhou 510663, P.R. China
Tel:+86-20-32296118
Email:sales@medprin.com
About Medprin
Medprin is short for “Medical Printing”. Medprin specializes in research, development, and manufacturing of the high-end medical devices, with successful technology transformation of Class III implantable medical devices such as ReDura™, NeoDura™, and Recranio™, etc.. Products are available in more than 80 countries and regions and have benefited more than 350,000 patients.
Copyright © 2023 Medprin. All rights reserved.
Privacy Policy / Terms of Use /